Xalatan (latanoprost) NDC 58151-419

NDC codes

FDA NDC Directory

Product NDC (as listed)58151-419Labeler and product segments. Claims need a package NDC.

Product NDC at billing width58151-0419Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
58151-419-35	58151041935	1 BOTTLE, DROPPER in 1 CARTON (58151-419-35) / 2.5 mL in 1 BOTTLE, DROPPERMarketed from Oct 22, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Xalatan
Generic name (nonproprietary): latanoprost
Active ingredients: Latanoprost — 50 ug/mL
Dosage form: Solution/ drops
Route: Ophthalmic
Labeler: Viatris Specialty LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 020597
Marketing start: Oct 22, 2024
Listing expires: Dec 31, 2026
Identifiers: Product ID 58151-419_45489b8b-2aab-4336-8552-1524493289f9SPL ID 45489b8b-2aab-4336-8552-1524493289f9SPL set ID a98595b3-9f47-48e0-b18d-550a2095f264RxCUI 314072, 542527UNII 6Z5B6HVF6O

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Ophthalmic products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N458151041935 followed by a unit qualifier and the quantity

Package 58151-0419-35. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective May 15, 2023.

Indications (excerpt from the label)

XALATAN is indicated for the reduction of elevated intraocular pressure (IOP) in patients with open-angle glaucoma or ocular hypertension. XALATAN is a prostaglandin F 2α analogue indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension. ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under NDA 020597

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under NDA 020597
Product	Strength	Form · route	Labeler	Product NDC
Latanoprost	Latanoprost 50 ug/mL	SolutionOphthalmic	Mylan Pharmaceuticals Inc.	59762-0333